Biomarker Confirms Efficacy of Early Drug Switch for Prostate Cancer Patients

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

Innovative Immunotherapy More Effective in Treating an Aggressive Lymphoma than Chemotherapy

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the U.S. could be more effective than chemotherapy, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

Alan Astrow

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Research

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported

8 Weill Cornell Medicine Neurosurgeons Among Top Doctors in New York 2016

The Weill Cornell Medicine Brain & Spine Center is once again proud to have eight members of our team included in New York magazine’s annual listing of the “Best Doctors of New York.”

This prestigious roster includes:

Cold Caps Help Prevent Hair Loss from Chemotherapy

WABC's Emmy-nominated digital series "Medical Marvels" recently featured Weill Cornell Medicine's clinical study about Dignicap, a scalp cooling system designed to prevent hair loss.

Soo Jung Cho

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Research

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported

Bradley Hayward

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Research

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported

Devan Bhagat

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Research

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported

WCM Receives $100K Grant from the Bill & Melinda Gates Foundation for International Study

Weill Cornell Medicine received a $100,000 Grand Challenges Explorations Grant from the Bill & Melinda Gates Foundation to develop maps that will help researchers better study antimicrobial resistance in 54 cities.

Physician Communication Needed to Promote Informed Decision-Making for Patients with Advanced Cancer

Researchers at Weill Cornell Medicine urge physicians to discuss patients' conditions and life expectancies after a recent study found that just 5 percent of advanced cancer patients fully understood their prognosis.